CarlinosideCAS# 59952-97-5 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 59952-97-5 | SDF | Download SDF |
PubChem ID | 442584 | Appearance | Powder |
Formula | C26H28O15 | M.Wt | 580.5 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-8-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one | ||
SMILES | C1C(C(C(C(O1)C2=C(C(=C(C3=C2OC(=CC3=O)C4=CC(=C(C=C4)O)O)O)C5C(C(C(C(O5)CO)O)O)O)O)O)O)O | ||
Standard InChIKey | XBGYTZHKGMCEGE-VYUBKLCTSA-N | ||
Standard InChI | InChI=1S/C26H28O15/c27-5-13-18(33)21(36)23(38)26(41-13)15-19(34)14-10(30)4-12(7-1-2-8(28)9(29)3-7)40-24(14)16(20(15)35)25-22(37)17(32)11(31)6-39-25/h1-4,11,13,17-18,21-23,25-29,31-38H,5-6H2/t11-,13+,17-,18+,21-,22+,23+,25-,26-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Carlinoside could be a worthy choice to intervene hyperbilirubinemia due to liver dysfunction. 2. Carlinoside upregulates Nrf2 gene expression, increases its nuclear translocation and stimulates UGT1A1 promoter activity. |
Targets | Nrf2 |
Carlinoside Dilution Calculator
Carlinoside Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.7227 mL | 8.6133 mL | 17.2265 mL | 34.4531 mL | 43.0663 mL |
5 mM | 0.3445 mL | 1.7227 mL | 3.4453 mL | 6.8906 mL | 8.6133 mL |
10 mM | 0.1723 mL | 0.8613 mL | 1.7227 mL | 3.4453 mL | 4.3066 mL |
50 mM | 0.0345 mL | 0.1723 mL | 0.3445 mL | 0.6891 mL | 0.8613 mL |
100 mM | 0.0172 mL | 0.0861 mL | 0.1723 mL | 0.3445 mL | 0.4307 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Malotilate
Catalog No.:BCC1196
CAS No.:59937-28-9
- 3',4'-dihydro-3'-hydroxy-Xanthyletin
Catalog No.:BCN3680
CAS No.:5993-18-0
- Vicriviroc maleate
Catalog No.:BCC2038
CAS No.:599179-03-0
- Vindesine sulfate
Catalog No.:BCC8266
CAS No.:59917-39-4
- HPI 1
Catalog No.:BCC3938
CAS No.:599150-20-6
- Vicenin -3
Catalog No.:BCN3014
CAS No.:59914-91-9
- 3-Hydroxy-8,9-methylenedioxypterocarpene
Catalog No.:BCN1407
CAS No.:59901-98-3
- Sulfasalazine
Catalog No.:BCC2545
CAS No.:599-79-1
- 3,3'-Sulfonyldianiline
Catalog No.:BCC8595
CAS No.:599-61-1
- Medicagenic acid
Catalog No.:BCN3893
CAS No.:599-07-5
- Mesopsin
Catalog No.:BCN8050
CAS No.:5989-16-2
- Loliolid
Catalog No.:BCN3655
CAS No.:5989-02-6
- Tagitinin F
Catalog No.:BCN4101
CAS No.:59979-57-6
- Tagitinin A
Catalog No.:BCN4102
CAS No.:59979-61-2
- EDTA
Catalog No.:BCC7493
CAS No.:60-00-4
- Guanethidine Sulfate
Catalog No.:BCC3789
CAS No.:60-02-6
- H-Tyr-OH
Catalog No.:BCC3123
CAS No.:60-18-4
- Acetylcholine chloride
Catalog No.:BCN2197
CAS No.:60-31-1
- (6-)ε-Aminocaproic acid
Catalog No.:BCC4888
CAS No.:60-32-2
- Linoleic acid
Catalog No.:BCN3821
CAS No.:60-33-3
- Acetamide
Catalog No.:BCN4114
CAS No.:60-35-5
- Acetyl-Strophanthidin
Catalog No.:BCC8113
CAS No.:60-38-8
- Tetracycline
Catalog No.:BCC9176
CAS No.:60-54-8
- Methimazole
Catalog No.:BCC3812
CAS No.:60-56-0
Carlinoside reduces hepatic bilirubin accumulation by stimulating bilirubin-UGT activity through Nrf2 gene expression.[Pubmed:21801714]
Biochem Pharmacol. 2011 Nov 1;82(9):1186-97.
Accumulation of bilirubin, primarily because of its insolubility, has been found to be associated with liver diseases including jaundice. Free bilirubin is insoluble; its glucuronidation by bilirubin-UGT enzyme (UGT1A1) makes it soluble and eliminates it through urine and faeces. Taking CCl(4) induced rat liver dysfunction model, we demonstrated that suppression of UGT1A1 activity in rat liver increased serum bilirubin level which could be reversed by Carlinoside (Cln), a flavone glycoside. Although Cln is a flavone compound, it escaped self-glucuronidation in the intestine and readily absorbed. Kinetic study of microsomal UGT1A1 from HepG2 cells suggested that Cln enhanced enzyme activity by increasing V(max) without altering K(m). This altered V(max) was found to be due to UGT1A1 overexpression by Cln which was observed in both HepG2 and rat primary hepatocytes. Since Nrf2 is the transcription factor of UGT1A1, we examined whether Cln effect on UGT1A1 overexpression is mediated through Nrf2. In Nrf2 knock-out cells, Cln could not elevate UGT1A1 activity indicating Nrf2 to be its target. Cln significantly increased Nrf2 gene expression in HepG2 cells which was subsequently localized in nuclear region. Results from ChIP assay showed that Cln markedly augmented Nrf2 binding to UGT1A1 promoter that consequently enhanced reporter activity. Our findings therefore show that Cln upregulated Nrf2 gene expression, increased its nuclear translocation and stimulated UGT1A1 promoter activity. Total outcome of these events brought about a significant increase of bilirubin glucuronidation. Cln therefore could be a worthy choice to intervene hyperbilirubinemia due to liver dysfunction.
Compounds from Vitex polygama active against kidney diseases.[Pubmed:17981413]
J Ethnopharmacol. 2008 Jan 17;115(2):320-2.
Vitex polygama Cham. (Lamiaceae, formerly Verbenaceae) is a familiar Brazilian species popularly known as Taruma whose leaf tea has been used by population to treat kidney diseases. The aim of this research was to investigate the hydroalcoholic extract of leaves in order to isolate the active compounds. Hydroalcoholic extract of leaves was obtained by stirring the previous hexane and methanol extracted leaves residue with 50% aqueous MeOH solution by ultra-sonic mixing. The obtained extract was partitioned with n-butanol. The yielded fraction was subsequently submitted to several chromatographic procedures to lead to the isolation of O-glycosidicflavones orientin and isoorientin as well as C-glycosylflavones schaftoside and Carlinoside along with their isomers, known as potent anti-inflammatory, antinociceptive and antioxidant agents, then identified as the active constituents, justifying the folk use of the plant to combat and prevent kidney stone and inflammation.